Department of Biochemistry and Molecular Biology, University of Bucharest, Bucharest 050095, Romania.
Department of Collagen Research, Division of Leather and Footwear Research Institute, The National Research & Development Institute for Textiles and Leather, Bucharest 031215, Romania.
J Immunol Res. 2019 Feb 5;2019:4513108. doi: 10.1155/2019/4513108. eCollection 2019.
Burns are soft tissue injuries that require particular care for wound healing. Current tissue engineering approaches are aimed at identifying the most efficient treatment combinations to restore the tissue properties and function by using adapted scaffolds or delivery platforms for tissue repair and regeneration by triggering molecules. To reduce the inflammation associated with skin burns, the addition of an anti-inflammatory factor in these scaffolds would greatly increase the quality of the therapy. Therefore, this study is aimed at obtaining and validating a novel multiparticulate system based on a collagen matrix with controlled delivery of flufenamic acid anti-inflammatory drug for burn wound healing applications. In this work, we have characterized the properties and biocompatibility of these multiparticulate drug delivery systems (MDDS) and we have demonstrated their efficiency against burns and soft tissue lesions, particularly when the drug was microencapsulated, and thus with a controlled release. This study contributes to the advancement in therapy of burns and burn wound healing applications.
烧伤是一种软组织损伤,需要特别注意伤口愈合。目前的组织工程方法旨在通过使用适应的支架或用于组织修复和再生的输送平台,通过触发分子来识别最有效的治疗组合,以恢复组织特性和功能。为了减轻与皮肤烧伤相关的炎症,在这些支架中添加抗炎因子将极大地提高治疗质量。因此,本研究旨在获得和验证一种基于胶原基质的新型多颗粒系统,该系统具有控制释放的 flufenamic 酸抗炎药物,用于烧伤创面愈合应用。在这项工作中,我们已经对这些多颗粒药物输送系统 (MDDS) 的特性和生物相容性进行了表征,并证明了它们对烧伤和软组织损伤的有效性,特别是当药物被微囊化且具有控制释放时。这项研究为烧伤和烧伤创面愈合应用的治疗进展做出了贡献。